Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sustainable Development01:43

Sustainable Development

15.2K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.2K
Development of the Lymphatic System01:15

Development of the Lymphatic System

2.1K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.1K
Language Development01:22

Language Development

918
Children master language quickly and with relative ease, supported by both biological predisposition and reinforcement. B. F. Skinner (1957) proposed that language is learned through reinforcement, while Noam Chomsky (1965) argued that language acquisition mechanisms are biologically determined.
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
918
Development of Immunocompetence01:22

Development of Immunocompetence

906
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
906
Development of the Heart01:27

Development of the Heart

2.5K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.5K
Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

25.3K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin K3 alleviates brain injury and behavioral deficits by inhibiting neuroinflammation in intracerebral hemorrhage in vitro and in vivo.

International immunopharmacology·2026
Same author

A viable kinase-inactive RIPK3 D143N mouse model reveals its scaffold function in driving TNF-induced inflammatory disorder.

Cell death discovery·2026
Same author

Differential modulation of BK channels by simvastatin: Critical role of the auxiliary β4 subunit.

British journal of pharmacology·2026
Same author

De novo design of GPCR exoframe modulators.

Nature·2026
Same author

Endosome-phagophore linking assemblies for the degradation of membrane/extracellular proteins.

Nature communications·2025
Same author

Mechanistic insights into pharmacokinetic interactions between simvastatin and vismodegib: Implications for optimization of combination therapy in medulloblastoma.

Biochemical and biophysical research communications·2025
Same journal

Bithiophene Scaffold for PET Imaging and Photosensitization as a Novel Theranostic Platform Targeting Amyloid-β Aggregates.

ACS chemical neuroscience·2026
Same journal

Low Agonism and Balanced Pathway Modulation Distinguish an M1 Muscarinic Receptor Positive Allosteric Modulator Lacking Cholinergic Adverse Effects.

ACS chemical neuroscience·2026
Same journal

Imaging Synaptic Vesicle Protein SV2C with <sup>18</sup>F-UCB-F: An In Vitro Autoradiography and In Vivo NHP PET Study.

ACS chemical neuroscience·2026
Same journal

UBOX5 Modulates the Cognitive Dysfunction by Degrading HSP70 Protein in Sleep-Deprived Mice.

ACS chemical neuroscience·2026
Same journal

Involvement of Raphe Nuclei in Depressive-like Behaviors and Short-Term Memory in an Animal Model of Parkinson's Disease.

ACS chemical neuroscience·2026
Same journal

Comprehensive Evaluation of Indazole-Based Synthetic Cannabinoid Receptor Agonists with Aliphatic Tail Groups: In Vitro Activities, Metabolic Stability, and In Vivo Pharmacokinetics.

ACS chemical neuroscience·2026
See all related articles

Related Experiment Video

Updated: Feb 5, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.3K

Development of Adenosine A

Jiyue Zheng1, Xiaohu Zhang1, Xuechu Zhen1

  • 1Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences , Soochow University , Su Zhou , Jiangsu 215021 , P. R. China.

ACS Chemical Neuroscience
|September 11, 2018
PubMed
Summary
This summary is machine-generated.

Adenosine receptor A2A antagonists show promise for treating Parkinson's disease (PD), offering potential benefits beyond current dopamine therapies. Research highlights their role in addressing both motor and non-motor symptoms, offering new therapeutic avenues.

Keywords:
Adenosine receptorGPCRParkinson’s diseaseantagonist

More Related Videos

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

20.8K
Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
04:17

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

1.1K

Related Experiment Videos

Last Updated: Feb 5, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.3K
Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
14:22

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development

Published on: April 15, 2013

20.8K
Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
04:17

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

1.1K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurology

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder with substantial unmet medical needs.
  • Current dopamine-based treatments primarily manage motor symptoms but do not halt disease progression and have long-term side effects.
  • Non-motor symptoms like sleep disturbances, pain, and psychiatric issues are inadequately addressed by existing therapies.

Purpose of the Study:

  • To review recent advancements (2015-2018) in the development of adenosine receptor A2A antagonists for Parkinson's disease treatment.
  • To discuss the therapeutic potential of these antagonists in managing both motor and non-motor symptoms of PD.
  • To explore the challenges and opportunities associated with A2A antagonist-based therapies for PD.

Main Methods:

  • Literature review of scientific publications from 2015 to 2018 focusing on adenosine receptor A2A antagonists and Parkinson's disease.
  • Analysis of research data on the efficacy and safety of A2A antagonists in preclinical and clinical studies.
  • Synthesis of findings to evaluate the therapeutic potential and limitations of this drug class.

Main Results:

  • Adenosine receptor A2A antagonists have emerged as a significant area of research for PD treatment.
  • These compounds demonstrate potential in addressing motor deficits and may offer benefits for non-motor symptoms.
  • The efficacy and long-term impact of A2A antagonists require further investigation.

Conclusions:

  • Adenosine receptor A2A antagonists represent a promising therapeutic strategy for Parkinson's disease, potentially offering advantages over current treatments.
  • Further research and clinical trials are necessary to overcome challenges and fully realize the therapeutic opportunities of A2A antagonists in PD management.
  • This class of drugs could provide a more comprehensive approach to treating the multifaceted nature of Parkinson's disease.